CURRENT AFFAIRS

Detailed explanation-1: -The first drug is nirmatrelvir. It blocks the activity of a specific enzyme needed for the virus that causes COVID-19 to replicate. The second drug is an antiviral drug called ritonavir.

Detailed explanation-2: -Some people with COVID-19 who are immunocompromised or are receiving immunosuppressive treatment may benefit from a treatment called convalescent plasma. Your healthcare provider can help decide whether this treatment is right for you.

Detailed explanation-3: -Intravenous remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in adults and pediatric patients aged ≥28 days and weighing ≥3 kg.